Published in Clin Genet on June 01, 2005
Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing. PeerJ (2013) 1.26
Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations. J Law Med Ethics (2015) 1.02
Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis. Eur J Hum Genet (2010) 0.99
Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. Eur J Hum Genet (2009) 0.99
The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study. Eur J Hum Genet (2010) 0.98
Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet (2007) 0.97
Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children. Genet Test Mol Biomarkers (2011) 0.93
A family genetic risk communication framework: guiding tool development in genetics health services. J Community Genet (2013) 0.90
Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children. J Genet Couns (2008) 0.90
The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns (2008) 0.88
Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease. J Health Commun (2009) 0.87
Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families. J Genet Couns (2011) 0.85
Men in the women's world of hereditary breast and ovarian cancer--a systematic review. Fam Cancer (2009) 0.84
Public perceptions of ethical issues regarding adult predictive genetic testing. Health Care Anal (2009) 0.84
Families' experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population. Fam Cancer (2012) 0.83
An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. Fam Cancer (2011) 0.82
Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives. Fam Cancer (2010) 0.80
Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet (2012) 0.79
Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida). Cancer Epidemiol Biomarkers Prev (2010) 0.78
Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study. Hered Cancer Clin Pract (2013) 0.78
Support Seeking or Familial Obligation: An Investigation of Motives for Disclosing Genetic Test Results. Health Commun (2015) 0.78
Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers. Fam Cancer (2013) 0.75
Discussion of photoprotection, screening, and risk behaviors with children and grandchildren after melanoma genetic testing. J Community Genet (2015) 0.75
Cancers related to genetic mutations: important psychosocial issues for Canadian family physicians. Can Fam Physician (2006) 0.75
Social determinants of family health history collection. J Community Genet (2015) 0.75
Cancer worry among Norwegian male BRCA1/2 mutation carriers. Fam Cancer (2011) 0.75
A novel approach to screening for familial hypercholesterolemia in a large public venue. J Community Genet (2016) 0.75
A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocol. BMJ Open (2013) 0.75
Nursing advocacy in a postgenomic age. Nurs Clin North Am (2009) 0.75
Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med (1993) 28.86
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Interventions for promoting physical activity. Cochrane Database Syst Rev (2005) 5.83
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry (1991) 4.43
Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet (1998) 4.16
Hypernatraemia in infants as a cause of brain damage. Arch Dis Child (1967) 3.53
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
Integration of general-practitioner and specialist antenatal care. J R Coll Gen Pract (1978) 3.39
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet (1994) 3.05
The relationship between access and quality of urban green space with population physical activity. Public Health (2006) 2.85
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ (2011) 2.74
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. BMJ (1992) 2.68
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell (2001) 2.61
Is short stature a handicap? A comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature. J Pediatr (2000) 2.52
The painful arc syndrome. Clinical classification as a guide to management. J Bone Joint Surg Br (1977) 2.44
Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res (1991) 2.30
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet (1998) 2.27
Diet and Resistance to Infection II. The Effect of the Maternal Diet. Am J Public Health Nations Health (1937) 2.26
Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J (1982) 2.23
Concern for families and individuals in clinical genetics. J Med Ethics (2003) 2.22
Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22
Home safety education and provision of safety equipment for injury prevention. Cochrane Database Syst Rev (2007) 2.18
Familial cancer syndromes. Lancet (1994) 2.16
Rehabilitation of hemiparesis after stroke with a mirror. Lancet (1999) 2.13
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09
EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron (2001) 2.08
Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep (1995) 2.08
Psychosocial intervention with cancer patients: a review. Psychol Med (1983) 2.07
Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation (1998) 2.06
Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst (1998) 1.97
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens (1998) 1.96
RELATION OF FOOD INTAKE TO RESPONSE OF MICE INOCULATED WITH LANSING STRAIN OF MURINE POLIOMYELITIS VIRUS. Science (1943) 1.94
Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev (2001) 1.93
Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer (1996) 1.93
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer (2011) 1.86
Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer (1998) 1.85
Staphylococcus lugdunensis endocarditis. Aust N Z J Med (1997) 1.81
The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer (1999) 1.80
Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev (2000) 1.80
Ethical review of multi-centre research: a survey of local research ethics committees in the south Thames region. J R Coll Physicians Lond (1998) 1.80
Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty (1998) 1.78
Social class and changes in weight-for-height between childhood and early adulthood. Int J Obes (1988) 1.69
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer (2005) 1.68
Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med (1996) 1.65
The relationship between age and depressive symptoms in two national surveys. Psychol Aging (1992) 1.63
The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer (2007) 1.62
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess (2011) 1.59
A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. Br J Cancer (2001) 1.56
Stiff eyes in stiff-person syndrome. Neurology (2008) 1.56
Bayesian latent variable models for median regression on multiple outcomes. Biometrics (2003) 1.51
Stressful life events and symptom onset in HIV infection. Am J Psychiatry (1991) 1.50
Dramatic response to platinum in a patient with cancer with a germline BRCA2 mutation. Clin Oncol (R Coll Radiol) (2009) 1.49
An investigation of patients' motivations for their participation in genetics-related research. J Med Ethics (2010) 1.48
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer (2006) 1.48
Should female genital cosmetic surgery and genital piercing be regarded ethically and legally as female genital mutilation? BJOG (2012) 1.47
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer (2005) 1.46
The effect of information technology on the physician workforce and health care in isolated communities: the Canadian picture. J Telemed Telecare (1999) 1.46
Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics (2003) 1.46
Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (2002) 1.45
Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer (2012) 1.45
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer (2004) 1.43
Developing, assessing, and refining quality of care criteria for a CHAMPUS mental health services demonstration. QRB Qual Rev Bull (1991) 1.40
Simultaneous breast cancer in non-identical Ashkenazi Jewish twins: management dilemmas when genetic testing is negative. Clin Oncol (R Coll Radiol) (2000) 1.39
Mimics of metastases from testicular tumours. Clin Radiol (1990) 1.39
Maternal brain death and prolonged fetal survival. Obstet Gynecol (1989) 1.39
Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.39
'A profile of dentists working in the general and community dental services in Scotland in 1987'. Br Dent J (1989) 1.38
Twenty-year follow-up of aerobic power and body composition of older track athletes. J Appl Physiol (1985) (1997) 1.38
Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health (2005) 1.38
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer (2008) 1.37
Insulin resistance, insulin, proinsulin, and ambulatory blood pressure in type II diabetes. Hypertension (1994) 1.37
The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs (2011) 1.35
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Am J Hum Genet (1998) 1.35
Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol (2000) 1.35
A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet (1992) 1.34
Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer (2003) 1.33
Generalized equations for predicting functional capacity from treadmill performance. Am Heart J (1984) 1.33
Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema: a study of psychotherapeutic management. Psychol Med (1983) 1.28
Factors influencing the outcome of in-vitro fertilization with percutaneous aspirated epididymal spermatozoa and intracytoplasmic sperm injection in azoospermic men. Hum Reprod (1995) 1.26
Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res (1995) 1.25